Xiaolong Xu
- Cancer Research top 10%
- Pharmacology top 2%
- Pharmacological Effects of Natural Compounds 5
- Immunology top 10%
- Immune Response and Inflammation 6
- Molecular Biology top 10%
- Ginseng Biological Effects and Applications 6
- Gut microbiota and health 6
- Metabolomics and Mass Spectrometry Studies 4
-
- Autophagy in Disease and Therapy 7
- Sepsis Diagnosis and Treatment 5
-
- SARS-CoV-2 and COVID-19 Research 5
- Journals
- Nature (1 paper)Proceedings of the National Academy of Sciences (2 papers)Advanced Materials (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiaolong Xu
82 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 118
- Cancer Research 297
- Complementary and alternative medicine 159
- Pharmacology 166
- Immunology 340
- Molecular Biology 971
Countries citing papers authored by Xiaolong Xu
This map shows the geographic impact of Xiaolong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolong Xu more than expected).
Fields of papers citing papers by Xiaolong Xu
This network shows the impact of papers produced by Xiaolong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolong Xu. The network helps show where Xiaolong Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaolong Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 3 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 20 | |
| 9 | 2024 | 2 | |
| 10 | 2023 | 0 | |
| 11 | 2022 | 12 | |
| 12 | 2022 | 16 | |
| 13 | In vivo Monitoring and Assessment of Exogenous Mesenchymal Stem Cell-Derived Exosomes in Mice with Ischemic Stroke by Molecular Imaging | 2020 | 1 |
| 14 | Perfluorocarbons-Based 19F Magnetic Resonance Imaging in Biomedicine | 2020 | 1 |
| 15 | 2020 | 26 | |
| 16 | 2020 | 17 | |
| 17 | 2015 | 132 | |
| 18 | 2015 | 22 | |
| 19 | 2015 | 199 | |
| 20 | 2014 | 29 |
About Xiaolong Xu
Xiaolong Xu is a scholar working on Complementary and alternative medicine, Epidemiology and Immunology, having authored 93 papers that have together received 2.0k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (7 papers), Ginseng Biological Effects and Applications (6 papers), Gut microbiota and health (6 papers), Immune Response and Inflammation (6 papers), Pharmacological Effects of Natural Compounds (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Sepsis Diagnosis and Treatment (5 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). The work is most often cited by research in Cancer Research (297 citations), Complementary and alternative medicine (159 citations) and Pharmacology (166 citations). Xiaolong Xu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yuhong Guo, Jianqin Xu, Shasha He, Jingxia Zhao, Changrong Wan, Fenghua Liu, Peng Yin, Mingjiang Liu, Ning Wang and Qingquan Liu. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.